UNSPSC 51263145: Alprenolol hydrochloride

This classification denotes a beta-adrenergic blocking agent with the molecular formula C15H23NO2.ClH, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 2502C2OIRK, chemically known as 2-propanol, 1-(o-allylphenoxy)-3-(isopropylamino)-, hydrochloride but more generally known as alprenolol hydrochloride, which bears US NIH Compound Identifier 66368. European Medicines Agency schedules Alprenolol hydrochloride in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB00378MIG.

Most nations, for tariff and trade purposes, schedule alprenolol hydrochloride under HS 29221980 and SITC 51461. As of Q4 2014, ALPRENOLOL HYDROCHLORIDE remains US FDA's Preferred Term for this commodity. Alprenolol hydrochloride bears US NLM identifiers UMLS ID C0282044 and NCI Concept Code C81651. SMILES: CC(C)NCC(COC1CCCCC1CC=C)O.CL.

UNSPSC 51263145 Alprenolol hydrochloride is a Commodity code tracking a specific pharmaceutical product, but the recent state and local procurement activity associated with this code does not align with alprenolol hydrochloride procurement. Instead, the single identified opportunity involves Seminole County, Florida soliciting naloxone and drug deactivation systems—distinct products addressing opioid-overdose response and controlled-substance disposal rather than the beta-blocker cardiovascular medication the code nominates. State and local governments do not appear to be actively purchasing alprenolol hydrochloride through recent competitive procurements; the code shows no relevant recent activity that matches its nominal scope.

Seminole County released IFB 60459723LAS on June 30, 2026, seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries to the Seminole County Community Health Building in Sanford, Florida. The response deadline was July 26, 2026. The contract carries a two-year initial term with one-year renewal option, fixed-fee pricing, and E-Verify and drug-free workplace compliance requirements. FEMA funding may underpin the procurement, triggering additional federal environmental compliance obligations. This opportunity does not reflect purchasing under the alprenolol hydrochloride code itself and suggests either a misclassification in the source data or that the code sees minimal state and local purchasing volume at present.